Category: Diabetes

5 Cardiometabolic Health Topics You Can’t Miss at CMHC West 2019

With dozens of recently released revised clinical guidelines, breakthrough trial data, and newly approved drugs on the market, it is increasingly important for clinicians leading the fight against cardiometabolic disease to review the latest topics and industry developments. Explore how the most respected leaders of the industry are advancing cardiometabolic health and combating the growing epidemic of cardiovascular diseases through sessions spotlighting the most recent and relevant research.

Cardiovascular Disease
The American Heart Association estimates that someone dies of cardiovascular disease every 38 seconds, leaving CVD as the leading cause of death in the United States. Recent advances in cardiovascular medicine continue to address the problem, with greater usage of direct oral anticoagulants, new paradigms in mitral valve regurgitation management and a larger emphasis on technological devices playing a leading role in the ongoing battle against CVD.

New research reveals a correlation between diabetes and increased risk of cardiovascular and thrombotic adverse events in patients with CAD, PAD, and AF, suggesting that current antithrombotic strategies may need to be reevaluated. Learn more at the Antithrombotics in Diabetic Patients: Recent Clinical Trial Results session chaired by Deepak L. Bhatt, MD.

Obesity Management
In 2019, obesity stands as the second most prevalent CVD risk factor in the United States. The alarming rise in worldwide obesity paralleled with the increased incidence of type 2 diabetes mellitus suggests the need for impactful obesity management in the population.

As awareness of obesity complications grows, the focus turns to obesity management techniques such as tailoring nutritional plans specific to patients and their needs. Recent research on the benefits of bariatric surgery for cardiometabolic patients and its long-term effects will be presented alongside developments in pharmacotherapy for obese patients and lifestyle medicine. Learn more from world-renowned experts Dr. Robert E. Ratner and Dr. Ken Fujioka at Session I: Obesity and Lifestyle Medicine .

Heart Failure
The incidence of heart failure is the only form of heart disease that hasn’t decreased in over 30 years, with approximately 550,000 new cases diagnosed in the U.S. per year.  Technological advancements in cardiac devices and improved prevention and treatment methods have diminished the death rate, but cardiovascular disease remains the leading cause of death in the country. A growing need to identify the underlying metabolic causes of heart failure prompts new studies aimed at developing new therapies for patients and addressing the problem at its earliest stage.

Recent research points to the need for comprehensive therapeutic strategies targeting heart failure and type 2 diabetes to improve overall patient outcomes. Studies have revealed that antihyperglycemic therapy can prevent heart failure in patients with and without type 2 diabetes and can be used as a tool for optimizing HF patient care. Learn more about the connection between heart failure and diabetes, the latest advances in iron repletion therapy, and the most recent, relevant clinical research at Session III: Heart Failure and Hypertension .

Female Cardiometabolic Care
Cardiovascular disease is the leading cause of death in women, outnumbering deaths from all other causes combined. According to the American Heart Association, one in three women have some form of cardiovascular disease and recognizing women at risk of CVD is of tremendous public health importance. Studies have shown that under-recognition of heart disease in female patients is frequent and often leads to less aggressive treatment strategies and poorer outcomes. Comprehensive education, training,and awareness are necessary to ensure adequate future female cardiometabolic care.

Back by popular demand, the CMHC West Women’s Health Summit will cover an array of topics ranging from the intersection between breast cancer and CVD, to cardiometabolic risk in American Indians, Alaska native women, pregnancy and PCOS patients. The one-day workshop spearheaded by Dr. Pamela Morris, expert on female cardiovascular risk, will present an in-depth analysis of the intricacies related to female cardiometabolic care and the newest developments in prevention and management therapy. Explore the Women’s Health Summit agenda, the can’t-miss event in women’s healthcare of the year.

Diabetes Management
According to recent calculations, the CDC reports 100 million U.S. adults to be living with diabetes or prediabetes, with that number expected to rise to 592 million by 2035.
Only about 20% of diabetic individuals are under professional care, according to BioMed Central. A recent study on the future implications of diabetes projects that the condition will remain a major health crisis in America despite medical advances and prevention efforts.

Crucial to the control of this epidemic is successful diabetes management based on the most recent research and trial results. Adherence to new glycemic target guidelines, medication and treatment plans and the impact of real-world data on the treatment of patients with T2DM will be discussed in depth by expert faculty with decades of experience in diabetic care. Learn more about the newest developments in diabetic therapies, prevention, and management at Session IV: Diabetes Management.

CMHC West 2019: Advancing Cardiometabolic Health from East to West
The CMHC West conference allows attendees the opportunity to delve into three days of comprehensive clinical education, covering the key topics below, led by world-renowned faculty, clinicians and keynote speakers and guaranteed to leave attendees with the most up-to-date, applicable knowledge to incorporate into their practice.

You can still gain access to the latest clinical education and a panel of world-renowned speakers by signing up today for our can’t miss event in cardiometabolic health education.

Register Now 

Higher Egg and Cholesterol Consumption Increases Heart Disease and Death Risk

Contrary to 2010 guidelines, the new 2015-2020 Dietary Guidelines for Americans  from the U.S. Department of Health and Human Services no longer limits the consumption of dietary cholesterol, which used to be 300 mg per day, nor does it advise against eating eggs. In fact, the current dietary recommendations include weekly egg consumption as part of a healthy diet. On average, U.S. adults consume an average of 300 mg of dietary cholesterol per day and eat about three or four eggs per week. As the database of clinical research on the connection between high dietary cholesterol levels and heart disease continues to grow, there may be an increased need to reevaluate the current dietary recommendations.
A new Northwestern Medicine study found a link between egg and dietary cholesterol consumption, and a significantly higher risk of cardiovascular disease and death. Evaluating over 30,000 diverse U.S. adults and their diet histories, the research team discovered a correlation between the incidence of heart disease and the eating habits of participants.
Study Findings
Led by Wenze Zhong, the Northwestern team assessed the nutritional patterns of racially and ethnically diverse participants for up to 31 years of follow up and found that eating 300 mg of dietary cholesterol per day was associated with a 17% higher risk of incident cardiovascular disease. An 18% increase in the risk of all-cause deaths was revealed, with cholesterol as the driving factor behind these changes, independent of saturated or dietary fat consumption.
Additionally, the study reported a 6% increased risk of cardiovascular disease associated with high egg consumption as well as a rise of 8% in the risk of all-cause death. Eating three to four eggs per week was enough to raise the risk of these life-threatening consequences, while exercise and overall diet quality had no effect on the association between cholesterol and heart disease.
Eggs and Cholesterol
While eggs are well-known to be high in cholesterol, the notion that they raise the risk of heart disease has been heavily contested over decades. Previous studies have found no link between cardiovascular disease and egg consumption, although most of them had less diverse samples and shorter follow-up times. However, cholesterol, regardless of its source, has been indisputably associated with increased risk of heart disease.
Lowering cholesterol levels is an essential component of maintaining a healthy diet and lowering the risk of heart disease. Eliminating eggs could prove useful as they are notoriously cholesterol-rich; egg yolks themselves are one of the highest sources of most commonly consumed dietary cholesterol, containing up to 186 mg of dietary cholesterol in one large egg.
Based on the study, dietary cholesterol intake should remain low in order to minimize heart disease and death risks. Reducing cholesterol-rich foods such as eggs, red or processed meat, and high-fat dairy products is a key step in maintaining low cholesterol levels.  However, there is no indication that eggs and other high cholesterol foods need to be eliminated entirely, as they are good sources of important nutrients such as essential amino acids and iron.
Opting for egg whites instead of whole eggs, or eating eggs in moderation may be a sufficient preventative measure for some individuals. Adherence to a properly balanced, healthy diet should be recommended to all patients looking to lower their risk of heart disease.
Although the 2015-2020 Dietary Guidelines exclude dietary cholesterol limits, the change does not suggest that this factor is no longer important. Individuals should aim to eat as little dietary cholesterol as possible, while the study findings indicate that the current guidelines may need to be reassessed.